Table 2. Study sample and all patients with HPV⁺TSCC and a good clinical outcome, diagnosed in Stockholm between 2000–2006.

		Sample		All patients
		n=31		n=109
		n	%	n	%
Sex
	male	21	68%	84	77%
	female	10	32%	25	23%
Stage
	I	0	0%	1	1%
	II	2	6%	9	8%
	III	13	42%	36	33%
	IV	16	52%	63	58%
Differentiation
	low	20	65%	71	65%
	medium	11	35%	37	34%
	high	0	0%	1	1%
Treatment
	RT 1	31	100%	106	97%
	CRT 1	0	0%	3	3%
Age (years)
	mean	56.1		58.2
	median	56		57

¹Abbreviations: RT, radiotherapy; CRT, chemoradiotherapy.